Clinical trials assessing ototopical agents in the treatment of pain associated with acute otitis media in children.
Otalgia (ear pain) is one of the characteristic symptoms and best predictor of acute otitis media (AOM) in children. Although oral pain medications are the current mainstay for the treatment of AOM-associated otalgia, ototopical agents have been investigated as an alternative treatment strategy. To permit review and assessment of this treatment modality, a systematic literature search was conducted to identify all randomized, controlled trials of ototopical agents. Four trials were identified, including those examining ototopical benzocaine in combination with antipyrine, lidocaine, tetracaine, and herbal extracts. Although the current available evidence suggests ototopical agents may be safe and effective, we conclude that further studies with more rigorous methodology are needed to conclusively demonstrate their utility in this setting.
Jubilant Clinsys Inc., 8540 Colonnade Center Drive, Suite 407, Raleigh, NC 27615, United States.
Daniel N
DN
Wood
Nermina
N
Nakas
Christopher W
CW
Gregory
D000208:Acute Disease; D000287:Administration, Topical; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004433:Earache / Q000188:drug therapy*; D006801:Humans; D010033:Otitis Media / Q000188:drug therapy*; D059408:Pain Management / Q000379:methods*